This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université de Montréal directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $403,623
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
CIHR · 2018 · Principal investigator
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
Principal investigators: Lubell, William D; Chipperton, Paul; Chemtob, Sylvain
Keywords: Age-Related Macular Degeneration; Azacyclopeptide; Cluster Of Differentiation-36 Receptor (Cd36); Inflammation; Macrocyclization; Macrophage; Medicinal Chemistry; Optometry; Organic Synthesis; Peptide Science
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.